Biomerica Inc (BMRA): Operating Cash Flow
-$3.42M
Year ended 2026-05-31
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2026-05-31 | -$3.42M | n/m | 2026-08-31, From 2025-06-01 |
| 2025-05-31 | -$3.84M | n/m | 2026-08-31, From 2024-06-01 |
| 2024-05-31 | -$5.36M | n/m | 2025-08-29, From 2023-06-01 |
| 2023-05-31 | -$5.47M | n/m | 2024-08-28, From 2022-06-01 |
| 2022-05-31 | -$479.0K | n/m | 2023-08-25, From 2021-06-01 |
| 2021-05-31 | -$5.25M | n/m | 2022-08-29, From 2020-06-01 |
| 2020-05-31 | -$4.30M | n/m | 2021-10-14, From 2019-06-01 |
| 2019-05-31 | -$2.24M | n/m | 2020-08-31, From 2018-06-01 |
| 2018-05-31 | -$1.17M | n/m | 2019-08-29, From 2017-06-01 |
| 2017-05-31 | -$722.9K | n/m | 2018-08-29, From 2016-06-01 |
| 2016-05-31 | -$208.8K | n/m | 2017-08-29, From 2015-06-01 |
| 2015-05-31 | -$405.5K | n/m | 2016-08-29, From 2014-06-01 |
| 2014-05-31 | -$862.3K | n/m | 2015-08-31, From 2013-06-01 |
| 2013-05-31 | $1.39M | +845.7% | 2014-08-29, From 2012-06-01 |
| 2012-05-31 | $147.4K | -55.2% | 2013-08-29, From 2011-06-01 |
| 2011-05-31 | $328.8K | n/a | 2012-08-29, From 2010-06-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Biomerica Inc (BMRA) | 2026-05-31 | -$3.42M | n/m |
| Insight Molecular Diagnostics Inc. (IMDX) | 2025-12-31 | -$22.18M | n/m |
| Anbio Biotechnology (NNNN) | 2025-12-31 | -$6.74M | n/m |
| Aspira Women's Health Inc. (AWHL) | 2025-12-31 | -$7.03M | n/m |
| Volitionrx Ltd (VNRX) | 2025-12-31 | -$19.68M | n/m |
| Celldex Therapeutics, Inc. (CLDX) | 2025-12-31 | -$210.94M | n/m |
| Immucell Corp (ICCC) | 2025-12-31 | $2.48M | +591.6% |
| Alpha Teknova, Inc. (TKNO) | 2025-12-31 | -$8.65M | n/m |
| Intellia Therapeutics, Inc. (NTLA) | 2025-12-31 | -$394.74M | n/m |
Compare BMRA, IMDX, NNNN, AWHL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗